Introduzca una acción o criptomoneda en el cuadro de búsqueda para obtener un resumen
iZafe Group AB Series B
IZAFE-BiZafe Group AB (publ), a life-science company, engages in the research, development, and marketing of digital medical solutions and services for safer drug management at home. The company provides Dosell, an automated drug dispenser that handles dose bags, facilitates and enables independent medication, and reminds and alerts if the current dose is not taken at the right time. It serves consumers, and public and private-sector care providers in Sweden, the Nordic region, and internationally. The company has a collaboration with Zafe Care Systems AB and Sensorem AB. The company was formerly known as MediRätt AB (publ) and changed its name to iZafe Group AB (publ) in May 2019. The company was incorporated in 2008 and is headquartered in Stockholm, Sweden. Address: David Bagares Gata 3, Stockholm, Sweden, 111 38
Analytics
Precio Objetivo de WallStreet
3.23 SEKRelación P/E
–Rentabilidad por dividendo
–Año en curso
Año anterior
Trimestre actual
Último trimestre
Año en curso
Año anterior
Trimestre actual
Último trimestre
Cifras clave IZAFE-B
Análisis de dividendos IZAFE-B
Aumento del dividendo durante 5 años
–Crecimiento continuo
–Ratio de pago medio en 5 años
–Tendencia del payout IZAFE-B
Valoración de la acción IZAFE-B
Finanzas IZAFE-B
Realice un seguimiento de las métricas clave de cada acción en un solo lugar y sin complicaciones
Hazte premiumResultados | 2019 | Dinámica |